logo-loader
Aston Martin Lagonda Global Holdings PLC

JP Morgan lets some air out of Aston Martin's tyres as it predicts pricing pressure and "softening" demand

In a note, the US investment bank said the car maker's pricing power for its lower-cost vehicles could come under pressure in its 2019 fiscal year, which could affect as much as 15% of its sales

Aston Martin
The bank also cut its earnings forecasts for Aston's full year by 10%

Shares in Aston Martin Lagonda Global Holdings PLC (LON:AML) skidded in late-afternoon after JP Morgan cut its target price to 1,500p from 1,800p.

In a note, the US investment bank said the car maker's pricing power for its lower-cost vehicles could come under pressure in its 2019 fiscal year, which could affect as much as 15% of its sales.

READ: Aston Martin ‘more like BMW than Ferrari’ according to Deutsche Bank

Analysts also highlighted a “softening” of demand for premium models across Europe, citing low-single digit declines over the last five months as opposed to four years of “straight line growth” since 2015.

The bank also forecast that a lack of output in the first quarter from the group’s DBX luxury SUV model as well as higher depletion and amortisation (D&A), would “take a toll” on its first quarter results, and as such cut their earnings forecasts for the full year by 10%.

JP Morgan’s analysts aren’t the only ones expecting lower earnings from Aston Martin, with Deutsche Bank saying they saw a “risk to earnings in 2019” as a result of “muted demand momentum” and increasing costs due to ramp-ups at the company’s St Athan manufacturing plant.

Shares were down 0.6% at 931.4p.

Quick facts: Aston Martin Lagonda Global Holdings PLC

Price: £6.17

Market: LSE
Market Cap: £1.41 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

1 day, 18 hours ago

2 min read